M4MM

Curaleaf Reports Q2 2025 Financial Results

STAMFORD – Curaleaf Holdings, Inc., a major player in the global Cannabis market, released its financial and operational results for the second quarter of 2025, ending June 30, showcasing a blend of domestic resilience and ...

GTI Reports Q2 2025 Financial and Operational Results

CHICAGO & VANCOUVER – Green Thumb Industries Inc., a major player in the U.S. Cannabis market, national Cannabis consumer packaged goods (CPG) company, and operator of RISE Dispensaries, reported its financial and operational results for ...

Curaleaf Reports Q2 2025 Financial Results

STAMFORD – Curaleaf Holdings, Inc., a major player in the global Cannabis market, released its financial and operational results for the second quarter of 2025, ending June 30, showcasing a blend of domestic resilience and ...

GTI Reports Q2 2025 Financial and Operational Results

CHICAGO & VANCOUVER – Green Thumb Industries Inc., a major player in the U.S. Cannabis market, national Cannabis consumer packaged goods (CPG) company, and operator of RISE Dispensaries, reported its financial and operational results for ...

Medical Cannabis: Growth and Investment in 2024

LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...

Critics Slam Thai Government’s Approach to Cannabis

LOS ANGELES- Critics have strongly opposed the Thai government's plan to reclassify cannabis as a narcotic, arguing that it will harm businesses involved in cannabis-based products and undermine investor confidence in the country. On July ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands,  maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal year 2025 ...

Subscribe To Our Newsletter